Your session is about to expire
← Back to Search
Analgesia, patient controlled for Postoperative Pain
N/A
Waitlist Available
Research Sponsored by Mount Sinai Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 12 hours for up to 48 hours after randomization
Awards & highlights
Study Summary
The study aims to compare the use of intravenous patient controlled analgesia (IVPCA) versus the delivery of pain relief (per oral and intravenous (IV) medications as rescues analgesia) on an as needed basis within a well defined fast track protocol that includes multimodal analgesia for patients who are undergoing elective primary knee replacement surgery. The investigators assumed that with the multimodal analgesia regimen without the use of IVPCA will demonstrate decreased consumption of postoperative opioids, reduced incidence of opioids related side effects and decreased length of stay in the hospital.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Total amount of opioid consumption postoperatively
Secondary outcome measures
Length of stay in hospital
Opioid related side effects.
Pain scores measured at rest and movement
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Analgesia, patient controlledExperimental Treatment2 Interventions
Patients will be given a patient controlled analgesia (PCA) pump containing a standard solution of either morphine or hydromorphone.
Group II: Analgesia, as per neededActive Control2 Interventions
Patients will receive intravenous (IV) opioids as per needed.
Find a Location
Who is running the clinical trial?
Mount Sinai Hospital, CanadaLead Sponsor
196 Previous Clinical Trials
67,528 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger